Overview
Wiedemann-Rautenstrauch syndrome (WRS), also known as neonatal progeroid syndrome, is an extremely rare genetic disorder characterized by features of premature aging (progeria) that are apparent at birth. The condition affects multiple body systems, including the skin, skeletal system, adipose tissue, and central nervous system. Key clinical features include intrauterine growth restriction, a progeroid facial appearance with a triangular face, prominent scalp veins, sparse hair, a relatively large head with wide fontanelles, and a characteristic pattern of abnormal fat distribution with accumulation in the buttocks and flanks but generalized lipoatrophy elsewhere. Affected individuals typically have natal teeth (teeth present at birth), a small mouth, and a beaked or prominent nose. Additional features include short stature, failure to thrive, skeletal abnormalities, and variable degrees of intellectual disability. Many affected children experience significant feeding difficulties and recurrent infections. The prognosis is generally poor, with many affected individuals dying in infancy or early childhood, although some patients have survived into their teens or beyond. The syndrome is caused by biallelic pathogenic variants in the POLR3A gene, which encodes a subunit of RNA polymerase III, an enzyme critical for the transcription of small non-coding RNAs essential for cell growth and function. There is currently no cure or disease-specific treatment for Wiedemann-Rautenstrauch syndrome. Management is supportive and multidisciplinary, focusing on nutritional support (often requiring gastrostomy tube feeding), monitoring and managing skeletal complications, dental care, and addressing developmental delays through early intervention programs. Regular follow-up with multiple specialists including geneticists, neurologists, endocrinologists, and orthopedists is recommended to optimize quality of life and address complications as they arise.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Wiedemann-Rautenstrauch syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Wiedemann-Rautenstrauch syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Wiedemann-Rautenstrauch syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Wiedemann-Rautenstrauch syndrome.
Community
No community posts yet. Be the first to share your experience with Wiedemann-Rautenstrauch syndrome.
Start the conversation →Latest news about Wiedemann-Rautenstrauch syndrome
No recent news articles for Wiedemann-Rautenstrauch syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Wiedemann-Rautenstrauch syndrome
What is Wiedemann-Rautenstrauch syndrome?
Wiedemann-Rautenstrauch syndrome (WRS), also known as neonatal progeroid syndrome, is an extremely rare genetic disorder characterized by features of premature aging (progeria) that are apparent at birth. The condition affects multiple body systems, including the skin, skeletal system, adipose tissue, and central nervous system. Key clinical features include intrauterine growth restriction, a progeroid facial appearance with a triangular face, prominent scalp veins, sparse hair, a relatively large head with wide fontanelles, and a characteristic pattern of abnormal fat distribution with accumu
How is Wiedemann-Rautenstrauch syndrome inherited?
Wiedemann-Rautenstrauch syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Wiedemann-Rautenstrauch syndrome typically begin?
Typical onset of Wiedemann-Rautenstrauch syndrome is neonatal. Age of onset can vary across affected individuals.